Skip to main content
Premium Trial:

Request an Annual Quote

Most Viewed Articles on GWDN Last Week: Apr 2, 2012

NEW YORK (GenomeWeb News) – What were the articles that gained the most interest from GenomeWeb Daily News' readers last week? Here are the top five:

1) Roche Raises Bid to Acquire Illumina to $6.6B
2) Supreme Court Bounces Myriad BRCA Gene Patent Case Back to Appeals Court for Review
3) Roche Extends Takeover Offer for Illumina at Same Price
4) Columbia Sues Illumina for Infringement of NGS Patents
5) Sequestration Cuts 'Devastating' to NIH, Collins Tells Senate

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.